tirzepatide hot flashes Postmenopausal women on the GLP-1 medication (Zepbound) for obesity lost more weight if they were also using menopause hormone therapy, a retrospective cohort study indicated. https://www.medpagetoday.com/endocrinology/menopause/119594 GLP-1 Agonists in Perimenopause: Unique

doi:10.53738/REVMED.2022.18.792.1539 20

Additionally, about 28% of users discontinue therapy due to side effects such as nausea and gastrointestinal discomfort

Miller CB, Espie CA, Epstein DR, et al

Online prescribers typically complete an intake form, issue a prescription, and ship monthly no labs, no EKG, no body composition baseline, no physician reviewing your metabolic picture before determining candidacy, and limited clinical oversight if something changes

This gradual increase in Wegovy dose helps reduce the chance of side effects and lets your body get used to the medicine slowly

Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis